A platform for mechanistic modelling of subcutaneous administration with the effect of immunogenicity within the Open Systems Pharmacology framework PAGE 30 (2022) Abstr 10129 Pellowe M, Eriksson J, Chenel M, Sjögren E. ConferenceImmunologyPBPK/PBBMQSP Pharmetheus Affiliates Consultant Moriah Pellowe See bio Consultant Johanna Eriksson See bio Principal Consultant, PBPK & PBBM Platform Scientific Lead Erik Sjögren See bio Chief Research Officer Marylore Chenel See bio